|
Aug 7
|
Organigram Says Product Development Collaboration Completes Clinical Study on Nanoemulsion Technology
|
|
Aug 7
|
Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology
|
|
Aug 6
|
Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024
|
|
Jul 29
|
Organigram Announces Appointment of Craig Harris to Board of Directors
|
|
Jul 24
|
Update: Organigram Loses 4.7% as it Completes a Partial Third-Tranche Investment of US$1 Million in Phylos
|
|
Jul 24
|
Organigram Completes Partial Third Tranche Investment of US$1 Million in Phylos
|
|
Jul 24
|
Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos
|
|
Jul 23
|
US, Canadian pot firms eye Germany for growth as market stagnates at home
|
|
Jun 25
|
Organigram Invests in Sanity Group, a Leading German Cannabis Company
|
|
May 14
|
Organigram (OGI) Q2 2024 Earnings Call Transcript
|
|
May 14
|
Organigram Reports Second Quarter Fiscal 2024 Results
|
|
May 8
|
Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024
|
|
Apr 27
|
The Top 3 Cannabis Stocks to Buy in April 2024
|
|
Apr 26
|
Are Medical Stocks Lagging OrganiGram (OGI) This Year?
|
|
Apr 8
|
Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year
|
|
Apr 3
|
Organigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales
|
|
Apr 2
|
Organigram Successfully Closes Previously Announced Underwritten Public Offering
|
|
Mar 28
|
Why OrganiGram (OGI) Might Surprise This Earnings Season
|
|
Mar 27
|
Organigram Announces Pricing of Overnight Marketed Public Offering
|
|
Mar 26
|
Organigram Announces Launch of Overnight Marketed Public Offering
|